Fantom

ຕອນທ່ຽງຂອງລອນດອນ: ຮຸ້ນຮັກສາການເພີ່ມຂຶ້ນໃນຂະນະທີ່ຜູ້ຂຸດຄົ້ນບໍ່ແຮ່ເພີ່ມຂຶ້ນ, ປອນຫຼຸດລົງ

09 Jan 2025 08:21:23 By Buzz FX

UK Mid-Caps Hit Lowest Since April; European Stocks Erase Drop

09 Jan 2025 08:21:14 By Buzz FX

Trader Defies UK Gilt Turmoil With Wager on Five BOE Rate Cuts

09 Jan 2025 08:21:14 By Buzz FX

China Is A Clear And Urgent Threat To The UK, Labour MPs Warn

09 Jan 2025 08:16:24 By Buzz FX

EMERGING MARKETS: CEEMEA FX Price Signal Summary - EURPLN Resistance Intact

09 Jan 2025 08:16:24 By Buzz FX

OIL: CNR to Ramp Up Production in 2025: Reuters

09 Jan 2025 08:16:24 By Buzz FX

AZZ Inc. (NYSE:AZZ) Q3 2025 Earnings Call Transcript

09 Jan 2025 08:07:24 By Buzz FX

Informe de Asia: los mercados caen porque la inflación china no alcanza el objetivo anual

09 Jan 2025 08:07:24 By Buzz FX

Beijing is subsidizing everything from microwaves to dishwashers to get people to spend more money

09 Jan 2025 08:05:23 By Buzz FX

Greggs (LON:GRG) Stock Price Down 9.6% - Time to Sell?

09 Jan 2025 07:57:15 By Buzz FX

Endava plc (NYSE:DAVA) Receives Average Rating of "Moderate Buy" from Analysts

09 Jan 2025 07:57:15 By Buzz FX

Fed Finds New Reason for Confidence in Obscure Inflation Gauge

09 Jan 2025 07:57:15 By Buzz FX

Blend Labs, Inc. (NYSE:BLND) Receives Consensus Rating of "Moderate Buy" from Analysts

09 Jan 2025 07:57:15 By Buzz FX

Hello Group Inc. (NASDAQ:MOMO) Receives Consensus Rating of "Hold" from Brokerages

09 Jan 2025 07:57:15 By Buzz FX

UK Minister Says Gilt Markets 'Orderly', Demand for Debt Strong

09 Jan 2025 07:57:15 By Buzz FX

JD Sports Fashion Plc (LON:JD) Given Consensus Rating of "Moderate Buy" by Analysts

09 Jan 2025 07:56:14 By Buzz FX

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from Brokerages

09 Jan 2025 07:56:14 By Buzz FX

Enova International, Inc. (NYSE:ENVA) Given Consensus Recommendation of "Moderate Buy" by Analysts

09 Jan 2025 07:56:14 By Buzz FX

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of "Moderate Buy" by Analysts

09 Jan 2025 07:56:14 By Buzz FX

Structure Therapeutics Inc. (NASDAQ:GPCR) Receives Consensus Rating of "Buy" from Analysts

09 Jan 2025 07:56:14 By Buzz FX